the agents that have the greatest success in thrombotic disorders where platelet involvement is prominent include the prostaglandin pathway cyclo-oxygenase inhibitors aspirin and sulfinpyrazone , as well as dipyridamole .
C0005818
disorders
C0004057
aspirin